Related Experiment Video
Updated: May 3, 2026

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
Published on: August 12, 2017
Tissue-resident memory T cells in organ transplantation: implications for immune homeostasis and graft outcomes
Xinqiang Li1,2, Ruidong Ding1,2, Jinzhen Cai3,4
1Organ Transplantation Center, Affiliated Hospital of Qingdao University, Qingdao, China.
Tissue-resident memory T cells (TRMs) are a non-circulating subset of memory T cells that reside long-term in peripheral tissues. Once considered passive sentinels, TRMs are now recognized as active regulators of transplant immunity. This review summarizes their phenotypic and functional characteristics across key transplanted organs, including kidney, liver, lung, intestine, skin, and heart. Depending on their activation state and microenvironment, TRMs can promote rejection and modulate local immune balance. Advances in single-cell and spatial profiling have revealed TRM heterogeneity, donor-recipient dynamics, and distinct transcriptional programs. We also highlight therapeutic targets such as NKG2D, IL-15, RORγt, and PD-1, and discuss their potential as biomarkers and immunomodulatory tools. Understanding TRMs as both drivers and regulators of alloimmunity offers new strategies for improving transplant outcomes.
Tissue-resident memory T cells (TRMs) are a non-circulating subset of memory T cells that reside long-term in peripheral tissues. Once considered passive sentinels, TRMs are now recognized as active regulators of transplant immunity. This review summarizes their phenotypic and functional characteristics across key transplanted organs, including kidney, liver, lung, intestine, skin, and heart. Depending on their activation state and microenvironment, TRMs can promote rejection and modulate local immune balance. Advances in single-cell and spatial profiling have revealed TRM heterogeneity, donor-recipient dynamics, and distinct transcriptional programs. We also highlight therapeutic targets such as NKG2D, IL-15, RORγt, and PD-1, and discuss their potential as biomarkers and immunomodulatory tools. Understanding TRMs as both drivers and regulators of alloimmunity offers new strategies for improving transplant outcomes.
Related Concept Videos
Cell-mediated Immune Responses
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant I: Introduction
Cells of the Adaptive Immune Response
Special Features of Adaptive Immunity
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...

